Antitrust Suit Says Merck Blocking Generic Singulair
A group of drug wholesalers has filed a proposed class action against Merck & Co. Inc., alleging the drugmaker has engaged in anti-competitive tactics to block generic versions of its asthma...To view the full article, register now.
Already a subscriber? Click here to view full article